Regulation - Pricing, Generics

Filter

Current filters:

PricingGenerics

Popular Filters

Polish and European generics groups view opportunities for biosimilars

29-10-2014

The European Biosimilars Group – a sector group of the European Generic medicines Association, together…

BiosimilarsEastern EuropeGenericsMarkets & MarketingPolandPricingRegulation

Indian government takes action over dubious fixed-dose combinations

Indian government takes action over dubious fixed-dose combinations

30-09-2014

In a bid to weed out potentially unsafe combinations, the Central Drugs Standards and Control Organization…

Cadila PharmaGenericsIndiaPricingRegulation

Russian government plans to cut number of generics; controls on MNCs

Russian government plans to cut number of generics; controls on MNCs

23-06-2014

The number of drugs in the Russian market will decline significantly over the next several years, due…

GenericsPricingRegulationRussia

Colombia an attractive and fast-growing emerging pharma market

Colombia an attractive and fast-growing emerging pharma market

18-06-2014

The South American country Colombia has an attractive pharmaceutical market that should appeal to multinational…

ColombiaGenericsMarkets & MarketingPricingRegulationSouth America

“Generics, Get the Facts Straight” - subject of South Africa workshop

“Generics, Get the Facts Straight” - subject of South Africa workshop

29-10-2013

South Africa’s National Association of Pharmaceutical Manufacturers (NAPM) held a workshop for health…

GenericsPricingRegulationRest of the WorldSouth Africa

Generics market in Southeast Asia set for growth

15-09-2013

With its fast-growing, young population and uninsured majority in Southeast Asia, countries in the region…

Asia-PacificGenericsMarkets & MarketingPricingRegulation

EGA welcomes first biosimilar MAb approvals in Europe

12-09-2013

Following the European Medicines Agency's CHMP recommendation, the European Commission (EC) has just…

Anti-Arthritics/RheumaticsBiotechnologyGenericsPricingRegulation

Japan's MHLW approves 367 generics, but what does this mean?

21-08-2013

Japan's Ministry of Health Labor and Welfare (MHLW) approved 367 items of generic drugs last week. Launch…

Asia-PacificDiovanGenericsNovartisPharmaceuticalPricingRegulation

MEPS vote for access to cheaper generics drugs in Europe; mixed industry reaction

07-02-2013

European patients should have quicker access to cheaper "generic" medicines, according to Members of…

EuropeGenericsLegalPharmaceuticalPricingRegulation

More transparency on medicine pricing called for by EU parliamentarians

19-12-2012

More transparency and precise time limits for decision-making on pricing and reimbursement of medicines…

EuropeGenericsPharmaceuticalPricingRegulation

Moldova's pharmaceutical market over-regulated, study finds

05-12-2012

According to a study recently released by the Soros Foundation Moldova, the Moldavian pharmaceutical…

EuropeGenericsPharmaceuticalPricingRegulation

"India Pharma Inc" gearing up for the next level of growth

05-11-2012

Indian pharmaceutical companies will have to rethink business strategy in the light of several interventions…

Asia-PacificGenericsHealthcareMarkets & MarketingPharmaceuticalPricingProductionRegulation

Venezuelan govt increasing control over pharmaceutical sector

14-08-2012

Venezuela's national government has changed its policy with regard to the pharmaceutical sector. This…

FinancialGenericsPharmaceuticalPricingRegulationSouth America

European generics trade group urges addressing medicines affordability and availability risks

17-06-2012

With pensioners set to represent over 60% of the working population by 2060 in Europe, the pharmaceutical…

EuropeGenericsHealthcarePricingRegulation

Australia's PIC reports to Ministers on treatment and reimbursement of similar biologics

14-06-2012

The Australian Pharmaceuticals Industry Council (PIC), with industry group members AusBiotech, Medicines…

Asia-PacificBiotechnologyGenericsPharmaceuticalPricingRegulation

High expectations for new US biosimilars following FDA guidance documents

10-05-2012

In light of the upcoming FDA guidance for biosimilar approval, Novation, health care supply chain expertise…

BiotechnologyGenericsNorth AmericaPricingRegulation

Ukraine to introduce reference pricing and plans for prescription system

01-05-2012

The Ukraine Ministry of Health and domestic producers of pharmaceuticals have signed a memorandum of…

EuropeGenericsHealthcarePharmaceuticalPricingRegulation

Legislative changes to hamper near-term innovative drugs market in Central Europe

16-04-2012

Due to legislative changes implemented during 2011 in most of the Central European (CE) countries, the…

EuropeGenericsMarkets & MarketingPharmaceuticalPricingRegulation

COMPANY SPOTLIGHT

Menarini

Back to top